Aims: Tumour suppressor gene silencing through promoter hypermethylation plays an important role in oncogenesis. Carcinogenesis of hereditary cancers usually differs from that of their sporadic counterparts, but methylation has hardly been studied in hereditary ovarian cancer. The aim of this study was to investigate promoter methylation of a set of common tumour suppressor genes in BRCA1-related ovarian cancer in comparison with sporadic ovarian cancer.
Methods And Results: Methylation-specific multiplex ligation-dependent probe amplification was used to assess the extent of promoter methylation of 24 different tumour suppressor genes in BRCA1-associated (n = 25) and matched sporadic ovarian tumours (n = 50). A cumulative methylation index (CMI) was calculated and differences between individual genes were analysed. There was no significant difference in cumulative methylation between BRCA1-associated and sporadic ovarian carcinomas (median CMI 108; CMI 110; P = 0.86). Also, methylation patterns of individual genes did not show distinct differences after correction for multiple comparisons. CDH13, GSTP1 and RASSF1 were frequently methylated in both sporadic and hereditary ovarian cancers. BRCA1 methylation occurred in 14% of sporadic tumours, but was not detected in BRCA1-associated tumours.
Conclusions: CDH13, GSTP1 and RASSF1 are frequently methylated in both sporadic and BRCA1-associated ovarian cancers. Interestingly, methylation of BRCA1, while frequent in sporadic ovarian cancer, never occurred in the hereditary group. BRCA1-associated ovarian cancers mimic their sporadic counterparts in extent and pattern of promoter methylation of several common tumour suppressor genes. This finding could have implications for future chemotherapy regimens based on epigenetic changes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2559.2010.03642.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Tumour Microenvironment and Epigenetic Regulation in Pathogenic Variant-Associated Breast Cancers.
Cancers (Basel)
November 2024
Department of Anatomical Pathology, Division of Pathology, Singapore General Hospital, Singapore 169856, Singapore.
Article Synopsis
- Pathogenic variant (PV)-associated breast cancers are often linked to hereditary conditions like Hereditary Breast and Ovarian Cancer (HBOC) syndrome, showing more aggressive behavior and worse outcomes than sporadic cases.
- PVs affect the tumor microenvironment by interacting with immune and stromal cells, promoting processes like angiogenesis and epithelial-mesenchymal transition, as well as influencing epigenetic factors such as DNA methylation.
- Lysine-specific demethylase 1 (LSD-1) is a key epigenetic regulator linked to poor cancer prognosis, and inhibiting LSD-1 could offer a novel therapeutic strategy for managing breast cancer in patients with pathogenic variants.
Deciphering the causal landscape: genetic insights into sporadic vestibular schwannoma risk factors through Mendelian Randomization.
Discov Oncol
December 2024
Medical School of Chinese People's Liberation Army, Beijing, 100853, China.
Article Synopsis
- Sporadic vestibular schwannoma is a benign tumor impacting the vestibulocochlear nerve, leading to health issues like hearing loss and balance problems, while its causative factors remain under-researched.
- The study employs Two-Sample Mendelian Randomization to explore causal relationships between genetically predicted risk factors (like diseases and lifestyle habits) and sporadic vestibular schwannoma, using data from genome-wide association studies.
- Results indicate significant associations with factors such as ovarian cancer, dietary habits, and education level, suggesting that the development of sporadic vestibular schwannoma is influenced by a combination of genetic, hormonal, and lifestyle factors.
Burden of Reproductive Organ Cancer of Females in the Population-based Cancer Registry in Nepal.
J Nepal Health Res Counc
October 2024
Background: There are sporadic facility-based reports but an information gap in the cancer burden in the community is apparent. To address this, the Nepal Health Research Council (NHRC) started a Population-based Cancer Registry (PBCR) in 2018 in the country. Thus, this study aims to identify the cancer burden in the female population, especially in the reproductive organs.
View Article and Find Full Text PDFA patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers.
J Transl Med
November 2024
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Article Synopsis
- High-grade serous ovarian cancer (HGSC) shows resistance to immunotherapy but some patients have partial or complete responses, indicating a potential molecular basis for immunity in specific subpopulations.
- An algorithm called CONSTRU was developed to analyze gene expression profiles in HGSC and identify genetic factors that influence the effectiveness of anti-tumor immunity, resulting in a stratification signature (STRATsig) that divides patients into groups based on their immune response.
- Results indicated that patient survival and immune function varied significantly among these groups, with one group (S-T1) exhibiting strong immune suppression and dysfunction, while another group (S-T3) showed improved immune function, antigen presentation, and survival benefits correlated with genetic mutations.
Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles.
J Clin Invest
November 2024
Department of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
To identify novel genes responsible for recurrent hydatidiform moles (HMs), we performed exome sequencing on 75 unrelated patients who were negative for mutations in the known genes. We identified biallelic deleterious variants in 6 genes, FOXL2, MAJIN, KASH5, SYCP2, MEIOB, and HFM1, in patients with androgenetic HMs, including a familial case of 3 affected members. Five of these genes are essential for meiosis I, and their deficiencies lead to premature ovarian insufficiency.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!